-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Haemonetics, Raises Price Target to $86

Benzinga·08/07/2026 15:59:12
Listen to the news
JP Morgan analyst Allen Gong maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $62 to $86.